Abstract:OBJECTIVE: A substantial body of evidence suggests that obsessive-compulsive disorder has a genetic component, and substantial candidate genes for the disorder have been investigated through association analyses. A particular emphasis has been placed on genes related to the serotonergic system, which is likely to play an important role in the pathogenesis of obsessive-compulsive disorder. The gene for tryptophan hydroxylase 2, which is a rate limiting enzyme in serotonin synthesis is considered an important ca… Show more
“…For this reason, there has been renewed interest in the search for ‘endophenotypes’ (i.e. cognition dysfunctions), which are measurable disease‐associated traits that have a simpler relationship with underlying genes than with clinical measures (da Rocha et al in press).…”
Brain-derived neurotrophic factor (BDNF) gene has an important link to neurotransmitter systems, including serotonin, and seems to play a major role in emotional decision making. Impairment of decision making is an important feature of psychiatric disorders such as obsessive-compulsive disorder (OCD). We explore the link between decision making and the BDNF Val66Met polymorphism, which results in a reduction of BDNF activity, in a sample of Caucasian OCD patients. We used the Iowa Gambling Task (IGT) to measure decision making in 122 OCD patients. All patients were assessed using the Yale-Brown Obsessive-Compulsive Scale, the Beck Depression Inventory, the Beck Anxiety Inventory and the Raven Progressive Matrices. Patients also performed the Continuous Performance Task (CPT-II) and the Trail Making Test (TMT). We grouped Met-allele carriers because these act in a dominant way. Metallele carries exhibited low performance on both halves of the IGT (first half -F = −2.51, df = 120, P = 0.01; second half -F = −2.32, df = 120, P = 0.02). However, logistic regression analyses showed that the influence of the Met allele seemed to be restricted to the first half of the IGT [first half -β = 0.55, df = 1, P < 0.01, odds ratio (OR) = 5.62; second half -β = 0.32, df = 1, P = 0.15, OR = 2.30]. No differences were observed in tests used to evaluate executive functions associated with the dorsolateral prefrontal cortices (TMT and CPT-II, df = 120, P > 0.05 for both). Met-allele impairment may only be related to decisions made under ambiguous conditions. The null results involving TMT and CPT-II are possibly related to the dysfunction of the orbitofrontal cortices that is associated with OCD.
“…For this reason, there has been renewed interest in the search for ‘endophenotypes’ (i.e. cognition dysfunctions), which are measurable disease‐associated traits that have a simpler relationship with underlying genes than with clinical measures (da Rocha et al in press).…”
Brain-derived neurotrophic factor (BDNF) gene has an important link to neurotransmitter systems, including serotonin, and seems to play a major role in emotional decision making. Impairment of decision making is an important feature of psychiatric disorders such as obsessive-compulsive disorder (OCD). We explore the link between decision making and the BDNF Val66Met polymorphism, which results in a reduction of BDNF activity, in a sample of Caucasian OCD patients. We used the Iowa Gambling Task (IGT) to measure decision making in 122 OCD patients. All patients were assessed using the Yale-Brown Obsessive-Compulsive Scale, the Beck Depression Inventory, the Beck Anxiety Inventory and the Raven Progressive Matrices. Patients also performed the Continuous Performance Task (CPT-II) and the Trail Making Test (TMT). We grouped Met-allele carriers because these act in a dominant way. Metallele carries exhibited low performance on both halves of the IGT (first half -F = −2.51, df = 120, P = 0.01; second half -F = −2.32, df = 120, P = 0.02). However, logistic regression analyses showed that the influence of the Met allele seemed to be restricted to the first half of the IGT [first half -β = 0.55, df = 1, P < 0.01, odds ratio (OR) = 5.62; second half -β = 0.32, df = 1, P = 0.15, OR = 2.30]. No differences were observed in tests used to evaluate executive functions associated with the dorsolateral prefrontal cortices (TMT and CPT-II, df = 120, P > 0.05 for both). Met-allele impairment may only be related to decisions made under ambiguous conditions. The null results involving TMT and CPT-II are possibly related to the dysfunction of the orbitofrontal cortices that is associated with OCD.
“…Several studies have demonstrated that changes in the 5-HT system were critical in children with ODD [39, 40]. Moreover, the polymorphisms of TPH - 2 have been shown to be associated with ADHD [16, 41, 42], obsessive–compulsive disorder [43], and bipolar affective disorder [44]. Also, TPH -2 was found to be associated with major depression [45] and pathogenesis of depression in Chinese females [46] and suicidal behavior [47, 48].…”
Background: Oppositional defiant disorder (ODD) is a behavioral disorder of school-age population. It is well known that 5-HT dysfunction is correlated with impulsivity, which is one of the common characteristics of ODD. The enzyme tryptophan hydroxylase-2 (TPH-2) synthesizes 5-HT in serotonergic neurons of the midbrain raphe. The purposes of this study were to investigate the potential association of TPH-2 polymorphisms with susceptibility to ODD in a Han Chinese school population.Methods: Four polymorphisms (rs4570625, rs11178997, rs1386494 and rs7305115) of the TPH-2 gene were analyzed by using polymerase chain reaction and DNA microarray hybridization in a case-control study of 276 Han Chinese individuals (124 ODD and 152 controls).
Results:In single marker analyses,there was a significant difference in the genotype (χ 2 = 4.163, P = 0.041) and allele frequency (χ 2 = 3.930, P = 0.047) of rs1386494 between ODD and control groups. Haplotype analyses revealed higher frequencies of haplotypes TA (rs4570625-rs11178997), TAG (rs4570625-rs11178997-rs1386494), TAA (rs4570625-rs11178997-rs7305115) and TAGA (rs4570625-rs11178997-rs1386494-rs7305115), but lower frequencies of haplotypes GA (rs4570625-rs11178997) and GAG (rs4570625-rs11178997-rs1386494) in ODD compared to control groups.
Conclusions:These findings suggest the role of these TPH-2 gene variants in susceptibility to ODD. Some haplotypes might be the risk factors for Chinese Han children with ODD, while others might be preventable factors.
“…Some studies showed no significant differences in genotype frequency of the tryptophan hydroxylases TPH1 and TPH2 genes variants, encoding for the enzymes involved in serotonin synthesis (Delorme et al, 2006;Frisch et al, 2000;Han et al, 1999;Walitza et al, 2004). Conversely, other investigations reported haplotype association between TPH2 SNPs and the disorder (da Rocha et al, 2011;Mössner et al, 2006) or between rs4570625 and patients scrupulousness (Di Nocera et al, 2014).…”
Section: Serotonergic Systemmentioning
confidence: 92%
“…rs4680 ( Val158Met) COMT (Catechol-O-Methyltransferase) polymorphism was associated with OCD (S. ), gender-specifically (Alsobrook et al, 2002Denys et al, 2006a;Karayiorgou et al, 1997Karayiorgou et al, , 1999Melo-Felippe et al, 2016;Pooley et al, 2007;Poyurovsky et al, 2005;Taylor, 2013), depending on the age at onset (Tükel et al, 2013) or Y-BOCS (Yale-Brown Obsessive-Compulsive Scalethe most frequently used interview to rate the severity of symptoms (Goodman et al, 1989)) scores (Erdal et al, 2003), or in patients with alexithymia tracts (Koh et al, 2016). However, other reports did not find an association between rs4680 and OCD (Bellivier et al, 1998;Camarena et al, 2004;Cristina Cavallini et al, 1998;da Rocha et al, 2011;Delorme et al, 2006;Di Bella et al, 2002;Han et al, 1999;Mak et al, 2015;Mössner et al, 2006;Walitza et al, 2002).…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.